- CD300a/LMIR1 Antibody
- R&D Systems, a Bio-Techne Brand
- Pricing InfoSupplier PageView Company Product Page
- AF2640
- IRC1, CMRF-35-H9, CMRF35-H, CMRF35H9, IRC1/IRC2, IGSF12, CMRF35H, IRp60, CMRF-35H, CLM-8, CMRF35-H9, IRC2
- Human
- CD300a/LMIR1
- Goat
- 100 ug (also 25 ug)
- Unconjugated
- IgG
- Western Blot, ELISA
- CD300a molecule
- Polyclonal
- Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
- Mouse myeloma cell line NS0-derived recombinant human CD300a/LMIR1, Leu18-Gln178, Accession # Q9UGN4
- LYOPH
- Antigen Affinity-purified
- R&D Systems, a Bio-Techne Brand
- Primary Antibodies
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
Specifications/Features
Available conjugates: Unconjugated
Specificity: Detects human CD300a/LMIR1 in direct ELISAs and Western blots. In direct ELISAs, less than 2% cross-reactivity with recombinant human (rh) LMIR2, rhLMIR3, rhLMIR5, and rhLMIR6 is observed